Welcome OSET 2020 Attendees!

Faster Healing. Faster Recovery. Faster Return to Daily Life.

Support regenerative healing and functional recovery1 with the Amniox Family of Umbilical Cord Allografts, the go-to adjunctive therapy for surgical and chronic wound procedures.

Learn more about how our umbilical cord allografts deliver the natural properties of human birth tissue 1 to help manage and prevent complications in most complex surgical procedures.2-16

Clarix
  • Clarix
  • FLO Injectable
  • Neox
  • Clarix
  • FLO Injectable
  • Neox

Developed by pioneers in the field of regenerative medicine, CLARIX cryopreserved umbilical cord matrix delivers the benefits of amniotic tissue to facilitate the healing process across a range of surgical specialties.

With CLARIX, you’re able to transplant more of this innate biology to each surgical site, thus supporting a more structured healing environment, helping to manage regenerative healing, and facilitating your patient’s functional recovery.

Click here to download product information

CLARIX FLO umbilical cord based injectable, supports the management of clinically impactful outcomes1 without the potential complications associated with repeated steroid injections or unclear benefits of PRP. It offers immediate cushioning that helps create a regenerative healing environment.

Click here to download product information

With the umbilical cord as its primary platform, the NEOX family of products are used to manage chronic and complex wounds. NEOX is designed to meet the needs of clinicians and patients and comes in a variety of sizes, formulations and storage options.

Click here to download product information

Downloadable Resources

form

Supports decreased wound dehiscence and scar tissue formation to facilitate expedited wound healing and functional recovery16-24

Aids in reducing adhesion formation, and facilitates restoration of range of motion after tendon repair surgery and other soft tissue procedures17,23

UP TO 10X THICKER than amniotic membrane,25,26 which may increase longevity in the surgical site

Promote Regenerative Healing, Backed by Research

Our extensive research allows us to preserve and deliver the most functional allograft for your needs.

500K

Transplants

360

Clinical Publications

30Y

Research & Development

The Science Behind Our Products

The Amniox Family of Cryopreserved Umbilical Cord Allografts helps deliver the natural properties of human birth tissue to wound environments.1

We have a wide range of adjunct therapies for the management of regenerative healing and functional recovery of surgical, acute and chronic wounds.

Learn about the science behind our platform in the video below:

Exclusive Access to the Physician Portal

We take pride in what our advanced platform technology can do in the most complex medical conditions, as well as the vast body of scientific and clinical research which backs its use. The Physician Portal includes a variety of valuable educational resources to help you become more comfortable with our game-changing products so you may readily apply them in your clinical practice. Click Here to Access the Physician Portal

See What Others Are Saying about Amniox

Robert Anderson, M.D.

Titletown Sports Medicine and Orthopedics
Green Bay, WI

In this short excerpt from a recent webinar, Dr. Robert Anderson, Foot & Ankle specialist and Co-chair of the NFL’s Musculoskeletal Committee, shares his perspective and experience on the adoption of umbilical cord allografts in sports-related foot and ankle surgical procedures.

Gregory C. Berlet, M.D.

Orthopedic Foot and Ankle Center
Columbus, OH

Surgical Repair of the Peroneus Brevis Tendon

Click Here For Case Details

WILLIAM MARSTON, MD

Professor of Surgery and Chief Division of Vascular Surgery
University of North Carolina School of Medicine
Chapel Hill, NC

Watch Dr. William Marston as he presents the 1-year follow-up results to the Phase 2 Clinical Trial results for Amniox’s investigational new drug TTAX01.

References
Tseng SC. Invest Ophthalmol Vis Sci. 2016;57(5):ORSFh1‐ORSFh8.
Caputo WJ, Vaquero C, Monterosa A, et al. Wound Repair Regen. 2016;24(5):885-893.
Couture M. Wounds. 2016;28(7):217-25.
Marston WA, Lantis JC 2nd, Wu SC, et al. Wound Repair Regen. 2019;27(6):680-86.
Marston WA, Lantis JC 2nd, Wu SC, et al. Wound Repair Regen. 2020. Online ahead of print.
Raphael A. J Wound Care. 2016;25(Sup7):S10-17.
Raphael A, Gonzales J. J Wound Care. 2017;26(Sup10):S38-44.
Bemenderfer TB, Anderson RB, Odum SM, Davis WH. J Foot Ankle Surg. 2019;58(1):97-102.
DeMill SL, Granata JD, Berlet GC, et al. Surgical Technol Int. 2014;25:257-61.
Ellington J, Ferguson C. Surg Technol Int. 2014;25:63-67.
Garras D, Scott R. AOFAS Annual Meeting 2017.
Hanselman AE, Tidwell J, Santrock R. Foot Ankle Int. 2015;Feb;36(2):151-8.
Stewart CM. SunKrist J Trauma Emerg Med Acute Care. 2019;1(1):1-6.
Swan J. Surg Technol Int. 2014;25:73‐78.
Warner M, Lasyone L. Surg Technol Int. 2014;25:251-5.
Bemenderfer TB, Anderson RB, Odum SM, Davis WH. Effects of Cryopreserved Amniotic Membrane-Umbilical Cord Allograft on Total Ankle Arthroplasty Wound Healing. J Foot Ankle Surg. 2019;58(1):97-102.
DeMill SL, Granata JD, Berlet GC, et al. Safety Analysis of Cryopreserved Amniotic Membrane/Umbilical Cord Tissue in Foot and Ankle Surgery: A Consecutive Case Series of 124 Patients. Surgical Technol Int. 2014;25:257-61.
Ellington J, Ferguson C. The use of amniotic membrane/umbilical cord in first metatarsophalangeal joint cheilectomy: a comparative bilateral case study. Surg Technol Int. 2014;25:63-67.
Garras D, Scott R. Particulate Umbilical Cord/Amniotic Membrane for the Treatment of Plantar Fasciitis. AOFAS Annual Meeting 2017.
Hanselman AE, Tidwell J, Santrock R. Cryopreserved Human Amniotic Membrane Injection for Plantar Fasciitis: A Randomized, Controlled, Double-Blind Pilot Study. Foot Ankle Int. 2015 Feb;36(2):151-8.
Stewart CM. The Use of Cryopreserved Umbilical Cord in Open Reduction and Internal Fixation of Calcaneal Fractures. SunKrist J Trauma Emerg Med Acute Care. 2019;1(1):1-6.
Swan J. Use of Cryopreserved, Particulate Human Amniotic Membrane and Umbilical Cord (AM/UC) Tissue: A Case Series Study for Application in the Healing of Chronic Wounds. Surg Technol Int. 2014;25:73‐78.
Warner M, Lasyone L. An Open-label, Single-center, Retrospective Study of Cryopreserved Amniotic Membrane and Umbilical Cord Tissue as an Adjunct for Foot and Ankle Surgery. Surg Technol Int. 2014;25:251-5.
Papanna R, Moise KJ Jr, Mann LK, et al. Cryopreserved Human Umbilical Cord Patch for In-Utero Spina Bifida Repair. Ultrasound Obstet Gynecol. 2016;47(2):168-76.
Cooke M, Tan EK, Mandrycky C, He H, O’Connell J, Tseng SC. Comparison of cryopreserved amniotic membrane and umbilical cord tissue with dehydrated amniotic membrane/chorion tissue. J Wound Care. 2014;23(10):465-476.
Tan EK, Cooke M, Mandrycky C, et al. Structural and biological comparison of cryopreserved and fresh amniotic membrane tissues. J Biomaterial T Eng. 2014;4:379-388.